Do the existing staging systems for primary liver cancer apply to combined hepatocellular carcinoma-intrahepatic cholangiocarcinoma?

被引:0
|
作者
Qiang Zhou [1 ]
Hao Cai [1 ]
Ming-Hao Xu [1 ]
Yao Ye [2 ]
Xiao-Long Li [1 ]
Guo-Ming Shi [1 ]
Cheng Huang [1 ]
Xiao-Dong Zhu [1 ]
Jia-Bin Cai [1 ]
Jian Zhou [1 ]
Jia Fan [1 ]
Yuan Ji [2 ]
Hui-Chuan Sun [1 ]
Ying-Hao Shen [1 ]
机构
[1] Department of Liver Surgery,Liver Cancer Institute,Zhongshan Hospital,and Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education),Fudan University
[2] Department of Pathology,Zhongshan Hospital,Fudan University
基金
上海市自然科学基金;
关键词
D O I
暂无
中图分类号
R735.7 [肝肿瘤];
学科分类号
100214 ;
摘要
Background:The incidence of combined hepatocellular carcinoma-intrahepatic cholangiocarcinoma(c HCC-ICC) is relatively low,and the knowledge about the prognosis of c HCC-ICC remains obscure.In the study,we aimed to screen existing primary liver cancer staging systems and shed light on the prognosis and risk factors for c HCC-ICC.Methods:We retrospectively reviewed 206 c HCC-ICC patients who received curative surgical resection from April 1999 to March 2017.The correlation of survival measures with the histological types or with tumor staging systems was determined and predictive values of tumor staging systems with c HCC-ICC prognosis were compared.Results:The histological type was not associated with overall survival(OS)(P = 0.338) or disease-free survival(DFS)(P = 0.843) of patients after curative surgical resection.BCLC,TNM for HCC,and TNM for ICC stages correlated with both OS and DFS in c HCC-ICC(all P < 0.05).The predictive values of TNM for HCC and TNM for ICC stages were similar in terms of predicting postoperative OS(P = 0.798) and DFS(P = 0.191) in c HCC-ICC.TNM for HCC was superior to BCLC for predicting postoperative OS(P = 0.022) in c HCC-ICC.Conclusion:The TNM for HCC staging system should be prioritized for clinical applications in predicting c HCC-ICC prognosis.
引用
收藏
页码:13 / 20
页数:8
相关论文
共 50 条
  • [31] Primary Liver Carcinoma with Biphenotypic Differentiation: 22 Cases of Combined Hepatocellular Carcinoma-Cholangiocarcinoma
    Mathews, J.
    Chapman, W.
    Tan, B.
    Vachharajani, N.
    Brunt, E.
    LABORATORY INVESTIGATION, 2012, 92 : 419A - 419A
  • [32] Primary Liver Carcinoma with Biphenotypic Differentiation: 22 Cases of Combined Hepatocellular Carcinoma-Cholangiocarcinoma
    Mathews, J.
    Chapman, W.
    Tan, B.
    Vachharajani, N.
    Brunt, E.
    MODERN PATHOLOGY, 2012, 25 : 419A - 419A
  • [33] Primary Liver Carcinoma with Biphenotypic Differentiation: 23 Cases of Combined Hepatocellular Carcinoma-Cholangiocarcinoma
    Mathews, James
    Chapman, William C.
    Vachharajani, Neeta
    Tan, Benjamin
    Brunt, Elizabeth M.
    HEPATOLOGY, 2012, 56 : 473A - 473A
  • [34] Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The Liver Cancer Pooling Project
    Petrick, Jessica L.
    Campbell, Peter T.
    Koshiol, Jill
    Thistle, Jake E.
    Andreotti, Gabriella
    Beane-Freeman, Laura E.
    Buring, Julie E.
    Chan, Andrew T.
    Chong, Dawn Q.
    Doody, Michele M.
    Gapstur, Susan M.
    Gaziano, John Michael
    Giovannucci, Edward
    Graubard, Barry I.
    Lee, I-Min
    Liao, Linda M.
    Linet, Martha S.
    Palmer, Julie R.
    Poynter, Jenny N.
    Purdue, Mark P.
    Robien, Kim
    Rosenberg, Lynn
    Schairer, Catherine
    Sesso, Howard D.
    Sinha, Rashmi
    Stampfer, Meir J.
    Stefanick, Marcia
    Wactawski-Wende, Jean
    Zhang, Xuehong
    Zeleniuch-Jacquotte, Anne
    Freedman, Neal D.
    McGlynn, Katherine A.
    BRITISH JOURNAL OF CANCER, 2018, 118 (07) : 1005 - 1012
  • [35] Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The Liver Cancer Pooling Project
    Jessica L. Petrick
    Peter T. Campbell
    Jill Koshiol
    Jake E. Thistle
    Gabriella Andreotti
    Laura E. Beane-Freeman
    Julie E. Buring
    Andrew T. Chan
    Dawn Q. Chong
    Michele M. Doody
    Susan M. Gapstur
    John Michael Gaziano
    Edward Giovannucci
    Barry I. Graubard
    I-Min Lee
    Linda M. Liao
    Martha S. Linet
    Julie R. Palmer
    Jenny N. Poynter
    Mark P. Purdue
    Kim Robien
    Lynn Rosenberg
    Catherine Schairer
    Howard D. Sesso
    Rashmi Sinha
    Meir J. Stampfer
    Marcia Stefanick
    Jean Wactawski-Wende
    Xuehong Zhang
    Anne Zeleniuch-Jacquotte
    Neal D. Freedman
    Katherine A. McGlynn
    British Journal of Cancer, 2018, 118 : 1005 - 1012
  • [36] Coffee Consumption and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma by Sex: The Liver Cancer Pooling Project
    Petrick, Jessica L.
    Freedman, Neal D.
    Graubard, Barry I.
    Sahasrabuddhe, Vikrant V.
    Lai, Gabriel Y.
    Alavanja, Michael C.
    Beane-Freeman, Laura E.
    Boggs, Deborah A.
    Buring, Julie E.
    Chan, Andrew T.
    Chong, Dawn Q.
    Fuchs, Charles S.
    Gapstur, Susan M.
    Gaziano, John Michael
    Giovannucci, Edward L.
    Hollenbeck, Albert R.
    King, Lindsay Y.
    Koshiol, Jill
    Lee, I-Min
    Linet, Martha S.
    Palmer, Julie R.
    Poynter, Jenny N.
    Purdue, Mark P.
    Robien, Kim
    Schairer, Catherine
    Sesso, Howard D.
    Sigurdson, Alice J.
    Zeleniuch-Jacquotte, Anne
    Wactawski-Wende, Jean
    Campbell, Peter T.
    McGlynn, Katherine A.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2015, 24 (09) : 1398 - 1406
  • [37] Synchronous occurrence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in both lobes of the liver
    Topaloglu, Serdar
    Saglam, Kutay
    Calik, Adnan
    Cobanoglu, Umit
    Ozturk, Mehmet Halil
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2014, 25 (02): : 209 - 211
  • [38] Double primary hepatic cancer (hepatocellular carcinoma and intrahepatic cholangiocarcinoma) in a single patient: A case report
    Zhou, Rongxing
    Zhang, Minjia
    Cheng, Nansheng
    Zhou, Yong
    ONCOLOGY LETTERS, 2016, 11 (01) : 273 - 276
  • [39] Differential miRNA Analysis of Combined Hepatocellular-Cholangiocarcinoma in Comparison to Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Pilot Study
    Malik, Preeti
    Huang, Yan
    Castrodad-Rodriguez, Carlos
    Lin, Juan
    Loudig, Olivier
    Bhalla, Amarpreet
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 1137 - 1139
  • [40] Differential miRNA Analysis of Combined Hepatocellular-Cholangiocarcinoma in Comparison to Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Pilot Study
    Malik, Preeti
    Huang, Yan
    Castrodad-Rodriguez, Carlos
    Lin, Juan
    Loudig, Olivier
    Bhalla, Amarpreet
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 1137 - 1139